CLOBEX SPRAY 0.05% W/W [SIN15185P]

Product Info

CLOBEX SPRAY 0.05% W/W

[SIN15185P]

Indications / possibilities of use
Topical treatment of moderate to severe plaque-type psoriasis, from 18 years of age on.

Posology / method of administration
Clobex cutaneous spray is intended for use on the skin, the solution should be sprayed directly onto the affected areas twice daily and then rubbed in gently until completely absorbed. Hands should be washed carefully after application. Each cycle of treatment should be limited to 4 consecutive weeks. Treatment of a lesion has to be stopped as soon as disease control is achieved; the diagnostic is to be re-evaluated if there is no improvement observed after 2 weeks.
Not more than 50g of spray-solution should be used per week. No more than 35 sprays should be involved in one application, i.e. not more than 70 sprays per day. Clobetasol propionate belongs to the most potent class of topical corticosteroids (class IV/class I) and prolonged use may result in serious undesirable effects (see Warnings and Precautions). If treatment with a local corticosteroid is clinically justified beyond 4 weeks, a less potent corticosteroid preparation should be considered. Repeated but short courses of clobetasol propionate may be used to control exacerbations.
Clobex cutaneous spray should be used neither on the face nor on intertriginous areas (axillae and genitoanal regions, see “Warnings and precautions” – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).
The safety and efficacy of Clobex cutaneous spray in children and adolescents under 18 years of age have not been established so far. No data are available in this context.

Contra-indications
Clobetasol propionate is contraindicated in patients who are hypersensitive to Clobetasol propionate, to other corticosteroids, or to any ingredient in this preparation. Skin areas affected by bacterial and mycobacterial, viral, fungal, parasitic infections or ulcerous wounds. Must not be used in Children under 2 years of age Must not be applied to the eyes and eyelids (risk of glaucoma, risk of cataract).